IL-4 modulation of CD4+CD25+ T regulatory cell-mediated suppression

被引:48
作者
Pace, L
Pioli, C
Doria, G
机构
[1] Univ Roma Tor Vergata, Dept Biol, Lab Immunol, I-00133 Rome, Italy
[2] Ente Nazl Energie Alternat, Unit Biotechnol, Sect Toxicol & Biomed, Rome, Italy
关键词
D O I
10.4049/jimmunol.174.12.7645
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Murine CD4(+)CD25(+) T regulatory (Treg) cells were cocultured with CD4(+)CD25(-) Th cells and APCs or purified B cells and stimulated by anti-CD3 mAb. Replacement of APCs by B cells did not significantly affect the suppression of CD4+CD25- Th cells. When IL-4 was added to separate cell populations, this cytokine promoted CD4(+)CD25(-) Th and CD4(+)CD25(+) Treg cell proliferation, whereas the suppressive competence of CD4(+)CD25(+) Treg cells was preserved. Conversely, IL-4 added to coculture of APCs, CD4+CD25- Th cells, and CD4(+)CD25(+) Treg cells inhibited the suppression of CD4(+)CD25(-) Th cells by favoring their survival through the induction of Bcl-2 expression. At variance, suppression was not affected by addition of IL-13, although this cytokine shares with IL-4 a receptor chain. When naive CD4(+)CD25(-) Th cells were replaced by Th1 and Th2 cells, cell proliferation of both subsets was equally suppressed, but suppression was less pronounced compared with that of CD4+CD25- Th cells. IL-4 production by Th2 cells was also inhibited. These results indicate that although CD4(+)CD25(+) Treg cells inhibit IL-4 production, the addition of IL-4 counteracts CD4(+)CD25(+) Treg cell-mediated suppression by promoting CD4(+)CD25(-) Th cell survival and proliferation.
引用
收藏
页码:7645 / 7653
页数:9
相关论文
共 46 条
[1]   Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment [J].
Annacker, O ;
Burlen-Defranoux, O ;
Pimenta-Araujo, R ;
Cumano, A ;
Bandeira, A .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3573-3580
[2]   CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10 [J].
Annacker, O ;
Pimenta-Araujo, R ;
Burlen-Defranoux, O ;
Barbosa, TC ;
Cumano, A ;
Bandeira, A .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3008-3018
[3]   HIGH LEVELS OF BCL-2 PROTEIN IN CIRCULATING T-LYMPHOCYTES, BUT NOT B-LYMPHOCYTES, OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ARINGER, M ;
WINTERSBERGER, W ;
STEINER, CW ;
KIENER, H ;
PRESTERL, E ;
JAEGER, U ;
SMOLEN, JS ;
GRANINGER, WB .
ARTHRITIS AND RHEUMATISM, 1994, 37 (10) :1423-1430
[4]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[5]   IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice [J].
Biedermann, T ;
Zimmermann, S ;
Himmelrich, H ;
Gumy, A ;
Egeter, A ;
Sakrauski, AK ;
Seegmüller, I ;
Voigt, H ;
Launois, P ;
Levine, AD ;
Wagner, H ;
Heeg, K ;
Louis, JA ;
Röcken, M .
NATURE IMMUNOLOGY, 2001, 2 (11) :1054-1060
[6]  
Boursalian TE, 1999, J IMMUNOL, V162, P3795
[7]   Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide [J].
Caramalho, I ;
Lopes-Carvalho, T ;
Ostler, D ;
Zelenay, S ;
Haury, M ;
Demengeot, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (04) :403-411
[8]   Survival and homeostatic proliferation of naive peripheral CD4+ T cells in the absence of self peptide:MHC complexes [J].
Clarke, SRM ;
Rudensky, AY .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2458-2464
[9]   Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines [J].
Cosmi, L ;
Liotta, F ;
Angeli, R ;
Mazzinghi, B ;
Santarlasci, V ;
Manetti, R ;
Lasagni, L ;
Vanini, V ;
Romagnani, P ;
Maggi, E ;
Annunziato, F ;
Romagnani, S .
BLOOD, 2004, 103 (08) :3117-3121
[10]   Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice [J].
Erb, KJ ;
Ruger, B ;
vonBrevern, M ;
Ryffel, B ;
Schimpl, A ;
Rivett, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (02) :329-339